1. Home
  2. VRTX vs NKE Comparison

VRTX vs NKE Comparison

Compare VRTX & NKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRTX
  • NKE
  • Stock Information
  • Founded
  • VRTX 1989
  • NKE 1964
  • Country
  • VRTX United States
  • NKE United States
  • Employees
  • VRTX N/A
  • NKE N/A
  • Industry
  • VRTX EDP Services
  • NKE Shoe Manufacturing
  • Sector
  • VRTX Technology
  • NKE Consumer Discretionary
  • Exchange
  • VRTX Nasdaq
  • NKE Nasdaq
  • Market Cap
  • VRTX 96.6B
  • NKE 112.8B
  • IPO Year
  • VRTX 1991
  • NKE 1980
  • Fundamental
  • Price
  • VRTX $423.53
  • NKE $69.17
  • Analyst Decision
  • VRTX Buy
  • NKE Buy
  • Analyst Count
  • VRTX 26
  • NKE 25
  • Target Price
  • VRTX $491.78
  • NKE $82.54
  • AVG Volume (30 Days)
  • VRTX 1.4M
  • NKE 17.5M
  • Earning Date
  • VRTX 11-03-2025
  • NKE 09-30-2025
  • Dividend Yield
  • VRTX N/A
  • NKE 2.30%
  • EPS Growth
  • VRTX N/A
  • NKE N/A
  • EPS
  • VRTX 14.07
  • NKE 1.95
  • Revenue
  • VRTX $11,418,800,000.00
  • NKE $46,440,000,000.00
  • Revenue This Year
  • VRTX $10.92
  • NKE $1.89
  • Revenue Next Year
  • VRTX $9.55
  • NKE $5.20
  • P/E Ratio
  • VRTX $30.04
  • NKE $35.77
  • Revenue Growth
  • VRTX 10.46
  • NKE N/A
  • 52 Week Low
  • VRTX $362.50
  • NKE $52.28
  • 52 Week High
  • VRTX $519.88
  • NKE $82.44
  • Technical
  • Relative Strength Index (RSI)
  • VRTX 61.96
  • NKE 47.24
  • Support Level
  • VRTX $405.54
  • NKE $67.41
  • Resistance Level
  • VRTX $432.76
  • NKE $69.53
  • Average True Range (ATR)
  • VRTX 8.97
  • NKE 1.74
  • MACD
  • VRTX 1.62
  • NKE 0.33
  • Stochastic Oscillator
  • VRTX 71.05
  • NKE 64.03

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About NKE Nike Inc.

Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.

Share on Social Networks: